Michael Blackton

ARTICLES BY MICHAEL BLACKTON

• Contingency Planning For Quality In The Cell And Gene Sector Due To COVID-19

  12/7/2020

  Maintaining clinical trials during the COVID-19 pandemic has presented quite a challenge for those companies exploring novel therapies.

• COVID-19’s Impact On Patient Centricity

  4/20/2020

  Michael Blackton, VP QA CMC and John Lunger Chief Patient Supply Officer at Adaptimmune cover COVID-19's impact on patient centricity.

• Changes To Anticipate In A Post-COVID Climate

  4/13/2020

  In this brief video, Michael Blackton, VP QA CMC and John Lunger Chief Patient Supply Officer at Adaptimmune discuss changes to anticipate in the post-COVID climate.